img

Global CRISPR-Based Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CRISPR-Based Therapeutics Market Insights, Forecast to 2034

CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.
Market Analysis and InsightsGlobal CRISPR-Based Therapeutics Market
Global CRISPR-Based Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CRISPR-Based Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, CRISPR-Based Therapeutics key companies include Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific and Horizon Discovery Group, etc. Caribou Biosciences, Addgene, CRISPR THERAPEUTICS are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of CRISPR-Based Therapeutics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole CRISPR-Based Therapeutics market and estimated to attract more attentions from industry insiders and investors.
CRISPR-Based Therapeutics can be divided into Genome Editing, Genetic Engineering, gRNA Database/Gene Librar and CRISPR Plasmid, etc. Genome Editing is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
CRISPR-Based Therapeutics is widely used in various fields, such as Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, etc. Biotechnology Companies provides greatest supports to the CRISPR-Based Therapeutics industry development. In 2022, global % revenue of CRISPR-Based Therapeutics went into Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global CRISPR-Based Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CRISPR-Based Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Segment by Application


Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CRISPR-Based Therapeutics introduction, etc. CRISPR-Based Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CRISPR-Based Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR-Based Therapeutics Market Perspective (2018-2033)
2.2 Global CRISPR-Based Therapeutics Growth Trends by Region
2.2.1 CRISPR-Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR-Based Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 CRISPR-Based Therapeutics Market Dynamics
2.3.1 CRISPR-Based Therapeutics Industry Trends
2.3.2 CRISPR-Based Therapeutics Market Drivers
2.3.3 CRISPR-Based Therapeutics Market Challenges
2.3.4 CRISPR-Based Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CRISPR-Based Therapeutics by Players
3.1.1 Global CRISPR-Based Therapeutics Revenue by Players (2018-2023)
3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CRISPR-Based Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio
3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2022
3.5 Global Key Players of CRISPR-Based Therapeutics Head office and Area Served
3.6 Global Key Players of CRISPR-Based Therapeutics, Product and Application
3.7 Global Key Players of CRISPR-Based Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR-Based Therapeutics Breakdown Data by Type
4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033)
5 CRISPR-Based Therapeutics Breakdown Data by Application
5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size (2018-2033)
6.2 North America CRISPR-Based Therapeutics Market Size by Type
6.2.1 North America CRISPR-Based Therapeutics Market Size by Type (2018-2023)
6.2.2 North America CRISPR-Based Therapeutics Market Size by Type (2024-2033)
6.2.3 North America CRISPR-Based Therapeutics Market Share by Type (2018-2033)
6.3 North America CRISPR-Based Therapeutics Market Size by Application
6.3.1 North America CRISPR-Based Therapeutics Market Size by Application (2018-2023)
6.3.2 North America CRISPR-Based Therapeutics Market Size by Application (2024-2033)
6.3.3 North America CRISPR-Based Therapeutics Market Share by Application (2018-2033)
6.4 North America CRISPR-Based Therapeutics Market Size by Country
6.4.1 North America CRISPR-Based Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CRISPR-Based Therapeutics Market Size by Country (2018-2023)
6.4.3 North America CRISPR-Based Therapeutics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size (2018-2033)
7.2 Europe CRISPR-Based Therapeutics Market Size by Type
7.2.1 Europe CRISPR-Based Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe CRISPR-Based Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe CRISPR-Based Therapeutics Market Share by Type (2018-2033)
7.3 Europe CRISPR-Based Therapeutics Market Size by Application
7.3.1 Europe CRISPR-Based Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe CRISPR-Based Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe CRISPR-Based Therapeutics Market Share by Application (2018-2033)
7.4 Europe CRISPR-Based Therapeutics Market Size by Country
7.4.1 Europe CRISPR-Based Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe CRISPR-Based Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CRISPR-Based Therapeutics Market Size (2018-2033)
8.2 China CRISPR-Based Therapeutics Market Size by Type
8.2.1 China CRISPR-Based Therapeutics Market Size by Type (2018-2023)
8.2.2 China CRISPR-Based Therapeutics Market Size by Type (2024-2033)
8.2.3 China CRISPR-Based Therapeutics Market Share by Type (2018-2033)
8.3 China CRISPR-Based Therapeutics Market Size by Application
8.3.1 China CRISPR-Based Therapeutics Market Size by Application (2018-2023)
8.3.2 China CRISPR-Based Therapeutics Market Size by Application (2024-2033)
8.3.3 China CRISPR-Based Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CRISPR-Based Therapeutics Market Size (2018-2033)
9.2 Asia CRISPR-Based Therapeutics Market Size by Type
9.2.1 Asia CRISPR-Based Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia CRISPR-Based Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia CRISPR-Based Therapeutics Market Share by Type (2018-2033)
9.3 Asia CRISPR-Based Therapeutics Market Size by Application
9.3.1 Asia CRISPR-Based Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia CRISPR-Based Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia CRISPR-Based Therapeutics Market Share by Application (2018-2033)
9.4 Asia CRISPR-Based Therapeutics Market Size by Region
9.4.1 Asia CRISPR-Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CRISPR-Based Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia CRISPR-Based Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Details
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.1.5 Caribou Biosciences Recent Developments
11.2 Addgene
11.2.1 Addgene Company Details
11.2.2 Addgene Business Overview
11.2.3 Addgene CRISPR-Based Therapeutics Introduction
11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.2.5 Addgene Recent Developments
11.3 CRISPR THERAPEUTICS
11.3.1 CRISPR THERAPEUTICS Company Details
11.3.2 CRISPR THERAPEUTICS Business Overview
11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.3.5 CRISPR THERAPEUTICS Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.4.5 Merck KGaA Recent Developments
11.5 Mirus Bio LLC
11.5.1 Mirus Bio LLC Company Details
11.5.2 Mirus Bio LLC Business Overview
11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.5.5 Mirus Bio LLC Recent Developments
11.6 Editas Medicine
11.6.1 Editas Medicine Company Details
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.6.5 Editas Medicine Recent Developments
11.7 Takara Bio USA
11.7.1 Takara Bio USA Company Details
11.7.2 Takara Bio USA Business Overview
11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.7.5 Takara Bio USA Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Details
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.9.5 Horizon Discovery Group Recent Developments
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Details
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.10.5 Intellia Therapeutics Recent Developments
11.11 GE Healthcare Dharmacon
11.11.1 GE Healthcare Dharmacon Company Details
11.11.2 GE Healthcare Dharmacon Business Overview
11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.11.5 GE Healthcare Dharmacon Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR-Based Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 10. Global CRISPR-Based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global CRISPR-Based Therapeutics Market Share by Region (2018-2023)
Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global CRISPR-Based Therapeutics Market Share by Region (2024-2033)
Table 15. CRISPR-Based Therapeutics Market Trends
Table 16. CRISPR-Based Therapeutics Market Drivers
Table 17. CRISPR-Based Therapeutics Market Challenges
Table 18. CRISPR-Based Therapeutics Market Restraints
Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global CRISPR-Based Therapeutics Revenue Share by Players (2018-2023)
Table 21. Global Top CRISPR-Based Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
Table 22. Global CRISPR-Based Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of CRISPR-Based Therapeutics, Headquarters and Area Served
Table 25. Global Key Players of CRISPR-Based Therapeutics, Product and Application
Table 26. Global Key Players of CRISPR-Based Therapeutics, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2023)
Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2024-2033)
Table 32. Global CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global CRISPR-Based Therapeutics Revenue Share by Application (2018-2023)
Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global CRISPR-Based Therapeutics Revenue Share by Application (2024-2033)
Table 36. North America CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America CRISPR-Based Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 38. North America CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America CRISPR-Based Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 40. North America CRISPR-Based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. North America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Europe CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe CRISPR-Based Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 45. Europe CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe CRISPR-Based Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 47. Europe CRISPR-Based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 50. China CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. China CRISPR-Based Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 52. China CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. China CRISPR-Based Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia CRISPR-Based Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 56. Asia CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia CRISPR-Based Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 58. Asia CRISPR-Based Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 59. Asia CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia CRISPR-Based Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 65. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 66. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 68. Caribou Biosciences Company Details
Table 69. Caribou Biosciences Business Overview
Table 70. Caribou Biosciences CRISPR-Based Therapeutics Product
Table 71. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Caribou Biosciences Recent Developments
Table 73. Addgene Company Details
Table 74. Addgene Business Overview
Table 75. Addgene CRISPR-Based Therapeutics Product
Table 76. Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Addgene Recent Developments
Table 78. CRISPR THERAPEUTICS Company Details
Table 79. CRISPR THERAPEUTICS Business Overview
Table 80. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product
Table 81. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 82. CRISPR THERAPEUTICS Recent Developments
Table 83. Merck KGaA Company Details
Table 84. Merck KGaA Business Overview
Table 85. Merck KGaA CRISPR-Based Therapeutics Product
Table 86. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Merck KGaA Recent Developments
Table 88. Mirus Bio LLC Company Details
Table 89. Mirus Bio LLC Business Overview
Table 90. Mirus Bio LLC CRISPR-Based Therapeutics Product
Table 91. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Mirus Bio LLC Recent Developments
Table 93. Editas Medicine Company Details
Table 94. Editas Medicine Business Overview
Table 95. Editas Medicine CRISPR-Based Therapeutics Product
Table 96. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Editas Medicine Recent Developments
Table 98. Takara Bio USA Company Details
Table 99. Takara Bio USA Business Overview
Table 100. Takara Bio USA CRISPR-Based Therapeutics Product
Table 101. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Takara Bio USA Recent Developments
Table 103. Thermo Fisher Scientific Company Details
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific CRISPR-Based Therapeutics Product
Table 106. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Developments
Table 108. Horizon Discovery Group Company Details
Table 109. Horizon Discovery Group Business Overview
Table 110. Horizon Discovery Group CRISPR-Based Therapeutics Product
Table 111. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 112. Horizon Discovery Group Recent Developments
Table 113. Intellia Therapeutics Company Details
Table 114. Intellia Therapeutics Business Overview
Table 115. Intellia Therapeutics CRISPR-Based Therapeutics Product
Table 116. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 117. Intellia Therapeutics Recent Developments
Table 118. GE Healthcare Dharmacon Company Details
Table 119. GE Healthcare Dharmacon Business Overview
Table 120. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product
Table 121. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 122. GE Healthcare Dharmacon Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CRISPR-Based Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR-Based Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 11. Global CRISPR-Based Therapeutics Market Share by Application: 2022 VS 2033
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR-Based Therapeutics Report Years Considered
Figure 17. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global CRISPR-Based Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global CRISPR-Based Therapeutics Market Share by Region: 2022 VS 2033
Figure 20. Global CRISPR-Based Therapeutics Market Share by Players in 2022
Figure 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2022
Figure 23. North America CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America CRISPR-Based Therapeutics Market Share by Type (2018-2033)
Figure 25. North America CRISPR-Based Therapeutics Market Share by Application (2018-2033)
Figure 26. North America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 27. United States CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe CRISPR-Based Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 30. Europe CRISPR-Based Therapeutics Market Share by Type (2018-2033)
Figure 31. Europe CRISPR-Based Therapeutics Market Share by Application (2018-2033)
Figure 32. Europe CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 33. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. China CRISPR-Based Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 40. China CRISPR-Based Therapeutics Market Share by Type (2018-2033)
Figure 41. China CRISPR-Based Therapeutics Market Share by Application (2018-2033)
Figure 42. Asia CRISPR-Based Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 43. Asia CRISPR-Based Therapeutics Market Share by Type (2018-2033)
Figure 44. Asia CRISPR-Based Therapeutics Market Share by Application (2018-2033)
Figure 45. Asia CRISPR-Based Therapeutics Market Share by Region (2018-2033)
Figure 46. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. China Taiwan CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. India CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Share by Type (2018-2033)
Figure 54. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Share by Application (2018-2033)
Figure 55. Middle East, Africa, and Latin America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 56. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Israel CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. GCC Countries CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 63. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 64. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 65. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 66. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 67. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 68. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 70. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 71. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 72. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries